Abstract
Primary immunodeficiencies (PIDs) are a group of rare genetic diseases resulting in the impairment of one or more functions of the human immune system. Common variable immunodeficiency (CVID) is one of the most prevalent PIDs, yet despite extensive genetic analysis, most patients do not have a monogenetic diagnosis. This has led to the theory that CVID must be a polygenetic condition. An alternative theory to a monogenetic or polygenetic underlying cause of CVID is that it is epigenetic phenomena that are causal in the majority of CVID patients. I will briefly discuss epigenetic regulation in B-cell biology and development, current examples of epigenetic diseases causing CVID-like primary antibody deficiencies, and how these observations may guide future investigation into the role of epigenetics in CVID.
Similar content being viewed by others
References
Abou Zahr A, Saad Aldin E, Barbarotta L et al (2015) The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes. Expert Rev Anticancer Ther 15:1019–1036
Alberghini F, Petrocelli V, Rahmat M et al (2015) An epigenetic view of B-cell disorders. Immunol Cell Biol 93:253–260
Ameratunga R, Brewerton M, Slade C et al (2014) Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol 5:415
Angulo I, Vadas O, Garçon F et al (2013) Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science 342:866–871
Ansell SM (2015) DNA methylation in lymphoma: an opportunity? Blood 125:1848–1849
Arrowsmith CH, Bountra C, Fish PV et al (2012) Epigenetic protein families: a new frontier for drug discovery. Nat Rev Drug Discov 11:384–400
Aslani S, Mahmoudi M, Karami J et al (2016) Epigenetic alterations underlying autoimmune diseases. Autoimmunity 49:69–83
Bao Y, Cao X (2016) Epigenetic control of B cell development and B-cell-related immune disorders. Clin Rev Allergy Immunol 50:301–311
Basso K, Sumazin P, Morozov P et al (2009) Identification of the human mature B cell miRNome. Immunity 30:744–752
Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16:6–21
Bjornsson HT, Benjamin JS, Zhang L et al (2014) Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med 6:256ra135
Boisson B, Wang YD, Bosompem A et al (2013) A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(−) B cells. J Clin Invest 123:4781–4785
Bröske AM, Vockentanz L, Kharazi S et al (2009) DNA methylation protects hematopoietic stem cell multipotency from myeloerythroid restriction. Nat Genet 41:1207–1215
Buchbinder D, Nadeau K, Nugent D (2011) Monozygotic twin pair showing discordant phenotype for X-linked thrombocytopenia and Wiskott-Aldrich syndrome: a role for epigenetics? J Clin Immunol 31:773–777
Buelow BJ, Routes JM, Verbsky JW (2014) Newborn screening for SCID: where are we now? Expert Rev Clin Immunol 10:1649–1657
Carter RH, Fearon DT (1992) CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256:105–107
Chen K, Coonrod EM, Kumánovics A et al (2013) Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency. Am J Hum Genet 93:812–824
Chiu YK, Lin IY, Su ST et al (2014) Transcription factor ABF-1 suppresses plasma cell differentiation but facilitates memory B cell formation. J Immunol 193:2207–2217
Daniel JA, Nussenzweig A (2012) Roles for histone H3K4 methyltransferase activities during immunoglobulin class-switch recombination. Biochim Biophys Acta 1819:733–738
Del Rey M, O’hagan K, Dellett M et al (2013) Genome-wide profiling of methylation identifies novel targets with aberrant hypermethylation and reduced expression in low-risk myelodysplastic syndromes. Leukemia 27:610–618
Dominguez PM, Teater M, Chambwe N et al (2015) DNA methylation dynamics of germinal center B cells are mediated by AID. Cell Rep 12:2086–2098
Durandy A, Kracker S, Fischer A (2013) Primary antibody deficiencies. Nat Rev Immunol 13:519–533
Egger G, Liang G, Aparicio A et al (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457–463
Elia L, Condorelli G (2015) RNA (Epi)genetics in cardiovascular diseases. J Mol Cell Cardiol 89(Pt A):11–16
Fliegauf M, Bryant VL, Frede N et al (2015) Haploinsufficiency of the NF-κB1 subunit p50 in common variable immunodeficiency. Am J Hum Genet 97:389–403
Flinsenberg TW, Janssen WJ, Herczenik E et al (2014) A novel FcγRIIa Q27W gene variant is associated with common variable immune deficiency through defective FcγRIIa downstream signaling. Clin Immunol 155:108–117
Gaspar HB, Hammarström L, Mahlaoui N et al (2014) The case for mandatory newborn screening for severe combined immunodeficiency (SCID). J Clin Immunol 34:393–397
Gathmann B, Mahlaoui N, Gérard L et al (2014) Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 134:116–126
Goldman FD, Gurel Z, Al-Zubeidi D et al (2012) Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the Ikaros gene. Pediatr Blood Cancer 58:591–597
Gurion R, Vidal L, Gafter-Gvili A et al (2010) 5-azacitidine prolongs overall survival in patients with myelodysplastic syndrome–a systematic review and meta-analysis. Haematologica 95:303–310
Herglotz J, Unrau L, Hauschildt F et al (2016) Essential control of early B-cell development by Mef2 transcription factors. Blood 127:572–581
Hodges E, Molaro A, Dos Santos CO et al (2011) Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol Cell 44:17–28
Indrevær RL, Moskaug J, Paur I et al (2015) IRF4 is a critical gene in retinoic acid-mediated plasma cell formation and is deregulated in common variable immunodeficiency-derived B cells. J Immunol 195:2601–2611
Jeffries MA, Sawalha AH (2015) Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve? Expert Rev Clin Immunol 11:45–58
Jiang Y, Melnick A (2015) The epigenetic basis of diffuse large B-cell lymphoma. Semin Hematol 52:86–96
Keller MD, Jyonouchi S (2013) Chipping away at a mountain: genomic studies in common variable immunodeficiency. Autoimmun Rev 12:687–689
Keller M, Glessner J, Resnick E et al (2014) Burden of copy number variation in common variable immunodeficiency. Clin Exp Immunol 177:269–271
Knight JC (2013) Genomic modulators of the immune response. Trends Genet 29:74–83
Kondilis-Mangum HD, Wade PA (2013) Epigenetics and the adaptive immune response. Mol Aspects Med 34:813–825
Kracker S, Di Virgilio M, Schwartzentruber J et al (2015) An inherited immunoglobulin class-switch recombination deficiency associated with a defect in the INO80 chromatin remodeling complex. J Allergy Clin Immunol 135(998–1007):e1006
Kramer NJ, Wang WL, Reyes EY et al (2015) Altered lymphopoiesis and immunodeficiency in miR-142 null mice. Blood 125:3720–3730
Kuang FL, Luo Z, Scharff MD (2009) H3 trimethyl K9 and H3 acetyl K9 chromatin modifications are associated with class switch recombination. Proc Natl Acad Sci USA 106:5288–5293
Kuehn HS, Boisson B, Cunningham-Rundles C et al (2016) Loss of B Cells in patients with heterozygous mutations in IKAROS. N Engl J Med 374:1032–1043
Lenardo M, Lo B, Lucas CL (2016) Genomics of immune diseases and new therapies. Ann Rev Immunol 34:121–149
Levine M, Tjian R (2003) Transcription regulation and animal diversity. Nature 424:147–151
Li J, Jørgensen SF, Maggadottir SM et al (2015a) Association of CLEC16A with human common variable immunodeficiency disorder and role in murine B cells. Nat Commun 6:6804
Li YR, Zhao SD, Li J et al (2015b) Genetic sharing and heritability of paediatric age of onset autoimmune diseases. Nat Commun 6:8442
Lin YC, Jhunjhunwala S, Benner C et al (2010) A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat Immunol 11:635–643
Lin JL, Lee WI, Huang JL et al (2015) Immunologic assessment and KMT2D mutation detection in Kabuki syndrome. Clin Genet 88:255–260
Lindsley AW, Saal HM, Burrow TA et al (2016) Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome. J Allergy Clin Immunol 137(179–187):e10
Maggadottir SM, Li J, Glessner JT et al (2015) Rare variants at 16p11.2 are associated with common variable immunodeficiency. J Allergy Clin Immunol 135:1569–1577
Miyake N, Mizuno S, Okamoto N et al (2013) KDM6A point mutations cause Kabuki syndrome. Hum Mutat 34:108–110
Mok Y, Schwierzeck V, Thomas DC et al (2013) MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production. J Immunol 191:3037–3048
Morera L, Lübbert M, Jung M (2016) Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy. Clin Epigenetics 8:57
Ng SB, Bigham AW, Buckingham KJ et al (2010) Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 42:790–793
Obata Y, Furusawa Y, Hase K (2015) Epigenetic modifications of the immune system in health and disease. Immunol Cell Biol 93:226–232
Orange JS, Glessner JT, Resnick E et al (2011) Genome-wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol 127(1360–1367):e1366
Picard C, Al-Herz W, Bousfiha A et al (2015) Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015. J Clin Immunol 35:696–726
Pieper K, Grimbacher B, Eibel H (2013) B-cell biology and development. J Allergy Clin Immunol 131:959–971
Qamar N, Fuleihan RL (2014) The hyper IgM syndromes. Clin Rev Allergy Immunol 46:120–130
Revy P, Muto T, Levy Y et al (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102:565–575
Reynaud D, Demarco IA, Reddy KL et al (2008) Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros. Nat Immunol 9:927–936
Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6:597–610
Rodriguez A, Vigorito E, Clare S et al (2007) Requirement of bic/microRNA-155 for normal immune function. Science 316:608–611
Rodríguez-Cortez VC, Del Pino-Molina L, Rodríguez-Ubreva J et al (2015) Monozygotic twins discordant for common variable immunodeficiency reveal impaired DNA demethylation during naïve-to-memory B-cell transition. Nat Commun 6:7335
Shen T, Sanchez HN, Zan H et al (2015) Genome-wide analysis reveals selective modulation of microRNAs and mRNAs by histone deacetylase inhibitor in B cells induced to undergo class-switch DNA recombination and plasma cell differentiation. Front Immunol 6:627
Stanhope-Baker P, Hudson KM, Shaffer AL et al (1996) Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85:887–897
Szyf M (2010) Epigenetic therapeutics in autoimmune disease. Clin Rev Allergy Immunol 39:62–77
Tallmadge RL, Shen L, Tseng CT et al (2015) Bone marrow transcriptome and epigenome profiles of equine common variable immunodeficiency patients unveil block of B lymphocyte differentiation. Clin Immunol 160:261–276
Vaidyanathan B, Chaudhuri J (2015) Epigenetic codes programing class switch recombination. Front Immunol 6:405
Van De Ven AA, Warnatz K (2015) The autoimmune conundrum in common variable immunodeficiency disorders. Curr Opin Allergy Clin Immunol 15:514–524
Van De Ven AA, Compeer EB, Van Montfrans JM et al (2011) B-cell defects in common variable immunodeficiency: BCR signaling, protein clustering and hardwired gene mutations. Crit Rev Immunol 31:85–98
Van Schouwenburg PA, Davenport EE, Kienzler AK et al (2015) Application of whole genome and RNA sequencing to investigate the genomic landscape of common variable immunodeficiency disorders. Clin Immunol 160:301–314
Van Zelm MC, Reisli I, Van Der Burg M et al (2006) An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 354:1901–1912
Walter K, Bonifer C, Tagoh H (2008) Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse Cd19 locus. Blood 112:1673–1682
Walter K, Cockerill PN, Barlow R et al (2010) Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5. Oncogene 29:2927–2937
Weemaes CM, Van Tol MJ, Wang J et al (2013) Heterogeneous clinical presentation in ICF syndrome: correlation with underlying gene defects. Eur J Hum Genet 21:1219–1225
White CA, Pone EJ, Lam T et al (2014) Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses. J Immunol 193:5933–5950
Wiencke JK, Butler R, Hsuang G et al (2016) The dna methylation profile of activated human natural killer cells. Epigenetics 11:363–380
Xu S, Ou X, Huo J et al (2015) Mir-17-92 regulates bone marrow homing of plasma cells and production of immunoglobulin G2c. Nat Commun 6:6764
Zahnow CA, Topper M, Stone M et al (2016) Inhibitors of DNA methylation, histone deacetylation, and histone demethylation: a perfect combination for cancer therapy. Adv Cancer Res 130:55–111
Zan H, Casali P (2015) Epigenetics of peripheral B cell differentiation and the antibody response. Front Immunol 6:631
Zhang J, Dominguez-Sola D, Hussein S et al (2015a) Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat Med 21:1190–1198
Zhang Y, Su HC, Lenardo MJ (2015b) Genomics is rapidly advancing precision medicine for immunological disorders. Nat Immunol 16:1001–1004
Acknowledgments
This research was supported by the National Institute for Health Research Rare Disease Translational Research Collaboration (NIHR RD-TRC). The views expressed are these of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Rae, W. Indications to Epigenetic Dysfunction in the Pathogenesis of Common Variable Immunodeficiency. Arch. Immunol. Ther. Exp. 65, 101–110 (2017). https://doi.org/10.1007/s00005-016-0414-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-016-0414-x